Cardiopulmonary Bypass Equipment Market, by Product Type (Single Roller Pump and Double Roller Pump), by End User (Hospitals and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Si

Cardiopulmonary Bypass Equipment Market, by Product Type (Single Roller Pump and Double Roller Pump), by End User (Hospitals and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Cardiopulmonary bypass equipment is a machine which takes over the function of heart and lungs to maintain the circulation of blood and the oxygen content of the patient's body during coronary bypass heart surgery. This equipment also known as heart lung machine. Cardiopulmonary bypass machine consists of two main components, the pump and the oxygenator which remove oxygen-deprived blood from a patient's body and replace it with oxygen-rich blood through a series of hoses. Surgeons are able to perform coronary artery bypass grafting (CABG), for valve repair or repair of cardiac anomalies, and aortic aneurysm repairs, along with treatment of other cardiac-related diseases.

Market Dynamics

Increasing adoption of unhealthy dietary habits, lack of proper exercise, increasing stress, and sedentary lifestyles are increasing occurrences of heart-related diseases, especially heart failures. This in turn is increasing demand for cardiopulmonary bypass equipment, thus expected to boost market growth over the forecast period. For instance, in October 2021, according to the data published the World Health Organization, approximately 17.9 million people die from cardiovascular diseases, which is an estimated 31% of all deaths worldwide. Heart and blood vessels disorders comprise one of the main causes of death worldwide. Cardiovascular diseases (CVDs) are one of the leading causes of death, ranking first globally. According to the World Health Organization, approximately 7.4 million people die from coronary heart disease and 6.7 million people as a result of a stroke globally. A sedentary lifestyle increases insulin resistance, induces obesity, increases blood glucose levels, plasma lipids and prothrombotic factors. According to a recent report by World Health Organization, 1/3 of worldwide deaths are due to CV disease. According to a report from the American Heart Association, sedentary behavior is linked with increased CV-specific and overall mortality and regarded as a disease burden. Besides, different studies have also shown that higher sedentary time is related to depressive symptoms and decreased psychological well-being and health-related quality of life. Additionally, a study by the American Heart Association in 2021, with 10,261 adults found that individuals who have light, moderate or vigorous physical activity had a significantly lower risk for CV disease mortality, regardless of their metabolic risk factors.

Key features of the study:

• This report provides an in-depth analysis of the global cardiopulmonary bypass equipment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cardiopulmonary bypass equipment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cardiopulmonary bypass equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiopulmonary bypass equipment market

Detailed Segmentation:

• Global Cardiopulmonary Bypass Equipment Market, By Product Type:
• Single Roller Pump
• Double Roller Pump
• Global Cardiopulmonary Bypass Equipment Market, By End User:
• Hospitals
• Ambulatory Surgical Centres
• Global Cardiopulmonary Bypass Equipment Market, By Region:
• North America

By Country

• U.S.
• Canada
• Latin America

By Country

• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe

By Country

• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific

By Country

• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East

By Country

• GCC
• Israel
• Rest of Middle East
• Africa

By Region/Country

• South Africa
• Central Africa
• North Africa
• Company Profiles
• Medtronic Plc*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• Terumo Corporation
• Braile Biomedica
• Tianjin Medical

“*” marked represents similar segmentation in other categories in the respective section.